Tissue regeneration, such as pancreatic islet tissue propagation in vitro, could serve as a 37 promising strategy for diabetes therapy and personalized drug testing. However, such a 38 2 protocol has not been realized yet. Propagation could be divided by two steps, which are: (1) 39 expansion in vitro and (2) repeat passaging. Even the in vitro expansion of the islet has not 40 been achieved to date. Here, we describe a method to enable the expansion of islet clusters 41 isolated from pregnant mice or wild-type rats by employing a combination of specific 42 regeneration factors and chemical compounds in vitro. The expanded islet clusters expressed 43 insulin, glucagon and somatostatin, which are markers corresponding to pancreatic β cells, α 44 cells and δ cells, respectively. These different types of cells grouped together, were spatially 45 organized and functioned similarly to primary islets. Further mechanistic analysis revealed 46 that forskolin in our recipe contributed to renewal and regeneration, whereas exendin4 was 47 essential for preserving islet cell identity. Our results provide a novel method for the in vitro 48 expansion of islet clusters, which is an important step forward in developing future protocols 49 and medium used for islet tissue propagation in vitro. Such method is important for future 50 regenerative diabetes therapies and personalized medicine using large amounts of pancreatic 51 islets derived from the same person. 52 53
Introduction 54
Diabetes is characterized by insulin resistance and dysfunctional insulin secretion. Recent 55 progress in the generation of functional insulin-producing pancreatic β cells from stem cells 56 differentiation or transdifferentiation in vitro has shed light on cell-replacement therapies for 57 the treatment of diabetes 1-4 . However, compared to tissue/organ replacement therapy derived 58 from somatic islets of the same person for curing diabetes 5,6 , these methods still have the 59 following deficits: (1) The function of a tissue, such as pancreatic islets, cannot be fully 60 substituted by a single β cell type. Islets contain at least three main cell types, and together, 61 they contribute the functional integrity adaptations to responses to different physiological 62 changes 7-10 . In fact, recent reports indicate the essential roles of the islet circuit in maintaining 63 glucose metabolism homeostasis 7,10 . (2) The identity of the β cells generated from 64 transdifferentiation or stem cells is not defined, and their functions are not guaranteed. These 65 cells normally have different gene expression patterns or certain mutations compared to 66 somatic β cells. (3) Some of the β-like cells generated from stem cells may still have 67 pluripotency potential, which may correlate to a risk of tumour development. (4) Finally, 68 these cells may elicit unwanted immune responses. 69 Ideally, propagating islets isolated from the same patient to the desired number and then 70 transplanting them into the patient is a promising regenerative strategy for diabetes therapy 71 with benefits that stem cell or transdifferentiation based cell-replacement treatment cannot 72 match. This method will minimize the immune response, decrease the identity difference and 73 result in a better ability to adapt to different growth niche after transplantation. In addition, 74 the organoids generated from pancreatic islets propagated from patients can be used for drug 75 testing because they mostly modelling composition, architecture and function of primary 76 tissue. Recently, significant progress has been made in which somatic intestinal, gastric, 77 colonal, hepatic and pancreatic ducts were cultured and propagated to organoids in vitro 11-19 , 78 which lays the foundation for future regenerative therapy. However, these organoids mostly 79 exhibit epithelial properties and are difficult to be induced into endocrine cells. Thus, the in 80 vitro propagation of functional endocrine organoids especially islets, is still required to be 81
established. 82
Propagation of islets could be divided by two processes: 1) expansion of the islet cells in 83 vitro. 2) Propagating the expanded islet cells by multiple passages. Here, we reported a 84 method for 3D culture with a novel special medium recipe that enabled the in vitro expansion 85 of pancreatic islet clusters isolated from pregnant mice or wild-type rats. Further mechanistic 86 analysis suggested that forskolin (FSK) in the recipe is required for maintaining cell renewal 87 and regeneration, whereas exendin4 is essential for preserving islet identity. Therefore, our 88 results identified a method allowed an in vitro expansion of the pancreatic islet clusters, 89 which could be a key step for propagating patient-specific pancreatic islets for future 90 regenerative diabetes therapy. 91
92
Results 93
Recipe for the in vitro pancreatic islet expansion medium (PIEM) 94
To identify the optimal conditions for pancreatic islet expansion in vitro, we reviewed the 95 chemicals, proliferation and regeneration factors used in the culture of other organoids, such 96 as those in pancreatic ducts, cholangiocytes and hepatocytes 14,16,20,21 , and pancreatic islet 97 organoids derived from stem cells or fibroblasts ( Fig. 1 ) 1-4 . According to their reported 98 functions, these chemicals and factors are classified into the following groups: islet identity, 99 cell division and proliferation, and cell renewal and regeneration ( Fig. 1) . By screening 100 different combinations of compounds and factors, a medium composed of 12 chemicals and 101 hormones, as well as the general nutrient nicotinamide, B27 and GlutaMAX, was created and 102 was found to robustly support the in vitro expansion of dispersed islet clusters isolated from 103 pregnant mice or wild-type rats. We named this in vitro pancreatic islet expansion medium 104
PIEM. 105 106

Expansion of mouse islet clusters in vitro 107
Previous studies have shown that pregnant mouse islets maintain expansion ability in vivo, 108 whereas wild-type mouse islets undergo little expansion 22,23 . We therefore used islets from 109 both pregnant and wild-type mice, as pregnant mice could serve as an easier starting point for 110 investigating the regeneration process. We isolated pancreatic islets from both wild-type and 111 pregnant C57BL/6 mice by collagenase P perfusion, sedimentation and handpicking. These 112 pancreatic islets were separated into single cells or cell clusters by dispase II digestion and 113 mechanical dissociation. The single cells or cell clusters were cultured in 3-dimensional (3D) 114
Matrigel. Only dispersed islet clusters isolated from pregnant mice showed significant 115 expansion during nine-day culture ( Fig. 2a ). Approximately 5~15% of the pancreatic islet 116 clusters isolated from pregnant mice were able to expand from a surface area of 6,000-9,000 117 µm 2 (240-320 cells) to a surface area of 20,000-30,000 µm 2 (1300-2100 cells) ( Fig. 2a , c). In 118 contrast, the dispersed single islet cells from pregnant or wild-type mice or islet clusters from 119 wild-type mice showed no significant expansion ( Fig. 2b, d) . 120 We next used qRT-PCR to examine the expression of key islet markers in the expanded 121 islet clusters. The expanded islet clusters maintain expression of the crucial pancreatic β cell 122 markers insulin-1 (Ins1), insulin-2 (Ins2) and Mafa; the α cell markers glucagon (Gcg) and 123 Mafb; and the δ cell marker somatostatin (Sst) ( Fig. 2e ). 124
To confirm that specific cell types coexisted in the in vitro expanded islet clusters, which is 125 a hallmark of expanded islet clusters, we performed immunostaining for INSULIN, 126 GLUCAGON and SOMATOSTATIN, which are markers for pancreatic α cells, β cells and δ 127 cells, respectively. The result unambiguously identified that glucagon, insulin, and 128 somatostatin staining was present in different cells grouped together in the same expanded 129 islet clusters similar to primary islets (Fig. 3a, b and Supplementary Fig. S1a, b ). The 130 percentage of the α cells, β cells and δ cells are (12.4±3.67)%, (78±4.55)%, (7.68±1.26)% 131 respectively in propagated islet clusters, which is similar to the pancreatic islets isolated from 132 pregnant mice ( Fig. 3c ). Importantly, we also observed the co-localization of the pancreatic 133 transcription factors PDX1 and MAFA with the insulin, as well as the partial co-localization 134 of the NKX6.1 with the insulin in the same cells of expanded islet clusters， which is similar to 135 the pancreatic islets isolated from pregnant mice( Fig. 3d-f and Supplementary Fig. S1c-e ). 136 We next examined the functional integrity of the expanded islet clusters. In response to 137 combined stimulation with 20 mM glucose and 100 nM GLP-1, the expanded islet clusters 138 demonstrated a significant increase in insulin secretion, although with a smaller extent 139 compared to the pregnant mouse islets (Fig. 3g ). In response to high glucose stimulation, both 140 other labs and our lab have shown that UCN3 serves an endogenous paracrine factor secreted 141 by pancreatic β cells to stimulate endogenous somatostatin secretion from pancreatic δ 142 cells 7,10,24 . We therefore stimulated the expanded islet clusters with both glucose and UCN3 to 143 minimize the amount required for islet cluster usage. The in vitro expanded islet clusters 144 displayed significantly more somatostatin release in response to glucose and UCN3 145 stimulation ( Fig. 3h ). Moreover, the expanded islet clusters secreted more glucagon in 146 response to 25mM Arginine stimulation, hallmarking the normal function of pancreatic islet α 147 cells, which is similar to the pregnant mouse islets (Fig. 3i ). These results confirmed the 148 functional integrity of the in vitro expanded islet clusters isolated from pregnant mice. 149
Although the expanded pancreatic islet clusters showed similar SST and Glucagon 150 secretion compared to the primary isolated islets in response to specific physiological 151 stimulations, it is worth to note that their insulin secretion in response to the combined 152 stimulation of glucose and GLP-1 is significantly weakened. Some extent degeneration during 153 the islet expansion may occur during current in vitro expansion condition, which awaits for 154 further investigation and methods optimization in our future work. 155 156
Expansion of rat islet clusters in vitro 157
We then examined the expansion of the dispersed rat islet single cells and clusters in PIEM. 158 Similar to those from pregnant mice, approximately 5~15% of the rat pancreatic islet clusters 159 were able to expand from a surface area of 5,000-8,000 µm 2 (200~350 cells) to a surface area 160 of 20,000-25,000 µm 2 (1,000~1,900 cells), whereas dispersed rat islet single cells showed no 161 such expansion ability ( Fig. 4a, b ). Furthermore, qRT-PCR revealed that the expanded rat islet 162 clusters maintained the same expression of the α cell markers Gcg and Mafb as the primary 163 rat islets but showed significantly higher expression of the β cell markers Ins-1, Ins-2 and 164
Mafa and the δ cell marker Sst (Fig. 4c ). 165 166
Increased gene expression related to dedifferentiation, pluripotency and proliferation in 167
expanded islet clusters 168 We next examined whether the expanded islet clusters increased the expression level of 169 genes functionally associated with cell proliferation, renewal and regeneration, which are 170 important factors for in vitro regeneration. Importantly, significantly higher expression of 171 Ki67, Ccnd1 and Pcna was found in expanded islet clusters than in islets derived from 172 pregnant mice or wild-type rats, highlighting the increased proliferation ability of the 173 expanded islet clusters ( Fig. 5a, d ). Moreover, significantly higher Nanog and Sox9 174 expression were found in expanded islet clusters derived from both pregnant mice and rats 175 ( Fig. 5b, e ). These results provide putative explanations accounting for the better proliferation 176 and renewal abilities of isolated islet clusters than integral islets. 177 We suspected that these islets gained proliferation and pluripotency due to dedifferentiation. 178 Thus, we examined dedifferentiation markers in expanded islet clusters and compared them 179 with those in isolated pancreatic islets. Interestingly, the expanded islet clusters showed 180 significantly higher expression of Ngn3 and Hlxb9, markers that characterize pancreatic islet 181 progenitor cells ( Fig. 5c, f) . Although the expanded islet clusters derived from pregnant mice 182 showed higher expression of Gata6, they showed decreased expression of Gata4, both of 183 which are pancreatic progenitor markers ( Fig. 5c, f) . The protein expression of KI67 and 184 SOX9 in expanded islet clusters were confirmed by immunofluorescence, higher than in 185 primary islets ( Supplementary Fig. S2a-d) . Similarly, the expanded islet clusters derived from 186 rats did not display significant pancreatic progenitor characteristics, as they showed decreased 187 expression of Gata6 (Fig. 5c , f). The data suggested that these expanded islet clusters 188 underwent one-step dedifferentiation towards islet progenitor cells, but they did not ultimately 189 reach the pancreatic progenitor cell stage. Taken together, this one-step dedifferentiation of 190 isolated islet clusters cultured in PIEM towards pancreatic islet progenitor cells contributed to 191 the gain of cell proliferation, renewal and regeneration functions of expanded islet clusters. 192
193
Essential role of FSK and exendin4 in PIEM 194
During our formula component screening and recipe formation for PIEM, we identified that 195 FSK and exendin4 are both required for robust islet cluster expansion in vitro. It is known that 196 exendin4 induced cAMP accumulation after it activates GLP-1R and downstream Gs 197 proteins 25 . FSK is known as a cAMP agonist through direct binding to adenyl cyclase 26 . 198 Moreover, recent reports indicate that FSK is required for proliferation of liver organoids in 199 addition to A83-01 27 . Interestingly, removing FSK or exendin4 from PIEM has different 200 effects on the gene expression profiles of islet identity, proliferation, renewal and regeneration 201 markers. Removing FSK from PIEM had partial effects on islet identity and cell proliferation 202 markers, including decreased expression of Mafa, Sst and Ccnb1 (Fig. 6a, b ). In particular, 203 FSK was required for the expression of cell renewal and regeneration markers, including 204 Nanog and Sox17 (Fig. 6c ). In contrast, exendin4 was essential for islet identity and 205 proliferation because it maintained the expression of the pancreatic β cell markers Ins-1, Pdx1 206
and Mafa and the proliferation markers Ki67, Ccnb1 and Cdk4 (Fig. 6a, b ). In particular, 207 exendin4 was required for the expression of Ngn3 and Hxlb9, two islet progenitor markers 208 (Fig. 6d ). These results indicated that FSK in PIEM renders cell renewal and regeneration 209 ability to isolated islet clusters, whereas exendin4 is essential for maintaining islet β cell 210 identity, proliferation and dedifferentiation. The in vitro expansion of primary pancreatic β cells or pancreatic islet tissues has not been 215 reported before. Here, we developed a medium recipe, which we named PIEM, that enabled 216 the proliferation of dispersed islet clusters isolated from pregnant mice or wild-type rats in 217 vitro (Fig. 7) . Isolated islet clusters normally grow from an initial surface area of 5,000-9,000 218 µm 2 to a surface area of 20,000-30,000 µm 2 , with an estimated 5~8-fold increase in cell 219 number. Compared to primary pancreatic islets, expanded cell clusters have similar or higher 220 mRNA expression levels of insulin, glucagon and somatostatin, which are markers of 221 pancreatic β cells, α cells and δ cells, respectively. Expanded islet clusters demonstrated 222 normal insulin and somatostatin secretion in response to physiological stimulation and normal 223 glucagon secretion in response to amino acids, suggesting that the clusters recapitulate 224 specific functions of pancreatic islets. Immunostaining further confirmed that the cells 225 expressing insulin, glucagon and somatostatin were grouped together and spatially organized 226 in expanded islet clusters similar to primary islets. These data indicated that the expanded 227 islet clusters behave similar to an in vitro organoid, thus serving as an initial step for future 228 islet propagation methods developing in vitro. The ultimate goal of developing efficient 229 methods for propagation islets in vitro is to fulfil the demand for regenerative diabetes 230 therapy and personalized drug tests. 231
It is worth noting that we observed the expansion of islet clusters isolated from only 232 pregnant mice and wild-type rats in PIEM, not those isolated from wild-type mice. Pregnant 233 mice are well known for their increased pancreatic β cell proliferation [28] [29] [30] [31] , which provides a 234 useful starting point for testing medium recipes. Although we did not observe the 235 proliferation of islet clusters isolated from wild-type mice, we did observe the expansion of 236 islet clusters isolated from wild-type rats, which share more properties identical to human 237 islets than mouse islets. An urgent need is to test whether PIEM enables the expansion of 238 primary islet clusters isolated from human patients. 239
Another notable observation is that only dispersed islet clusters were able to proliferate in 240 vitro, whereas dispersed single primary islet cells could not. Two important factors may 241 contribute to this discrepancy. First, the islet clusters contain multiple cell types, which are 242 not only the origins of the different cell types in the finally expanded islet clusters but also 243 may form certain cell circuits and gradient hormone concentrations to support in vitro 244 expansion. Second, primary single cells must undergo harsher digestion than islet clusters, 245 which means that the extracellular parts of the membrane or matrix proteins, including 246 receptors, ion channels and transporters, may be digested and their function impaired. These 247 membrane or matrix proteins may be key for in vitro tissue expansion. Therefore, future 248 analysis of the different expression patterns and functions of membrane proteins and 249 signalling circuit differences between isolated islet clusters and single cells may provide more 250 clues for unravelling the secrets of the in vitro expansion of islets and provide guidance for a 251 better strategy for in vitro islet cluster expansion. 252 We noticed that expanded islet clusters have higher expression of Ngn3 and Hlxb9, which 253 are markers of pancreatic islet progenitor cells. Although the Nanog in islet clusters increased 254 approximately 10 fold compared to normal islets, however, this level is more mimic the whole 255 embryo tissue but much lower (more than 1,000 fold lower) than the embryo stem cells 256 ( Supplementary Fig. S2e ). Whether this amount Nanog is required for islet expansion and 257 propagation in vitro, and whether it has cancer potential require further investigation. This 258 observation indicated that in vitro expanded islets underwent certain dedifferentiation. 259
However, we doubt that the islet clusters gained proliferation ability through this 260 dedifferentiation. Further experiments with withdrawal of key chemicals in the medium will 261 test this hypothesis. For clinical usage, the in vitro expansion of 100 patient islets to 1 million 262 islets without significant gene mutations, while preserving pancreatic islet function, and 263 transferring them back to the patient to recover glucose homeostasis is ideal. However, the 264 current approach of PIEM allows only 5~8-fold growth of approximately 5%-15% of isolated 265 islet clusters. The expansion of the islet clusters was only observed in the first passage. 266 Therefore, it is unlikely to cause significant genomic instability. However, the current 267 acquired in vitro expanded islet cluster cells do not contain sufficient amounts for RNA-seq to 268 verify the gene expression profile or transplantation to confirm their in vivo functions. More 269 important, the final usage of in vitro propagated islet clusters for regenerative therapy to treat 270 diabetes in general require millions of pancreatic islets. Therefore, a future revision of the 271 current PIEM composition and method for in vitro islet propagation is in an urgent demand. 272 One of the future directions for the optimization of in vitro islet propagation methods could 273 be as follows: (1) initial expansion and dedifferentiation of islet clusters to islet 274 progenitor-like cell clusters, (2) rapid proliferation of islet progenitor-like cell clusters to a 275 sufficient amount, (3) differentiation of progenitor-like cell clusters to functional integral 276 islets, (4) transplantation or (5) exploitation of these expanded islet tissues for drug tests. 277 Therefore, manifesting the markers for each stage and searching chemicals that are useful for 278 each procedure in the above protocol is our next goal to fulfil expanded islet clusters 279 regeneration in vitro in the future. 280
Taken together, we have developed a recipe for PIEM, and our 3D culture method enabled 281 the initial generation of expanded islet clusters via the in vitro expansion of isolated islet 282 clusters from pregnant mice or wild-type rats in the first passage. Our study is one important 283 step forward for the realization of a method to fulfil in vitro propagation of pancreatic islet in 284 vitro, which may facilitate new therapies development to treat diabetes. 
Pancreatic islet isolation and digestion into single cells or cell clusters. 297
We isolated pancreatic islets from C57BL/6 mice, pregnant C57BL/6 mice and Wistar rat. 298
Briefly, mice and rat were killed by cervical dislocation and then pancreas were isolated from 299 them individually. Adult pancreas were digested by Collagenase P (Roche, 11213873001) at 300 37 for 18-25 minutes. Digestion was stopped by cold Hank's balanced salt solution (136.9 301 mM NaCl; 5.4 mM KCl; 1.3 mM CaCl 2 ; 0.8 mM MgSO 4 ; 0.44 mM KH 2 PO 4 ; 0.34 mM 302 Na 2 HPO 4 ; 5.55 mM D-glucose; 4.4 mM NaHCO 3 , pH=7.4) followed by sedimentation for 303 three or five times at 4 . The islets were collected by hand picking using a stereomicroscope 304 and were cultured overnight in islet complete media containing 5.6 mM glucose (Biological 305 Industries), 10% FBS (Gibco),0.1% penicillin/streptomycin.Next we obtained single cells and 306 cell clusters of different diameters (20-150µm)under the microscope by controlling enzyme 307 concentration, digestion and settling time. Islets briefly after naturally settling for 1 minute in 308 KRBB buffer (135 mM NaCl; 4.7 mM KCl; 1.2 mM KH 2 PO 4 ; 10 mM Hepes; 3 mM 309 D-glucose; 5 mM NaHCO 3 ; 0.1% BSA; 1% penicillin/streptomycin, pH=7.4), preheated 310 EDTA-KRBB solution was added, gently piped for 2 min, then placed in a 33 water bath for 311 10 min; after clearing the supernatant, digested with dispase II(0.1-0.5 U/ml, Roche, 312 04942078001) in a 33 water bath for 3~8 min to obtain single cells or islet cell clusters. 
Production of Rspo1-conditioned medium 319
The RSPO1 conditioned medium is home-made and will be described in other papers. 320 321
Expanded islet clusters culture 322
Isolated islet cell clusters were washed twice with DMEM/F-12 (Biological Industries), 323 counted and mixed with Matrigel in glass centrifuge tubes. 30,000-50,000 cells or 10-20 cell 324 clusters were used per well of a pre-warmed 24-well plate (the volume of 50 µl). After 325
Matrigel was solidified for 30min at 37 , pancreatic islet expansion medium (PIEM) was Supplementary Table S1 . 349
350
Immunofluorescence staining 351
Expanded islet clusters were harvested using cell recovery solution (Corning, 354253) and 352 fixed in 4% paraformaldehyde for 30 min at room temperature, followed with blocking and 353 permeabilizing in PBS with 0.5% Triton X-100 (Solarbio, T8200) and 5% donkey serum 354 (Solarbio, SL050) for 30min at room temperature. Then, samples were incubated with 355 primary antibody at 4℃ overnight, followed by incubation with secondary antibody for 2h at 356 room temperature. DAPI (Beyotime, C1002) was used to stain the nucleus and find islets. The 
Insulin secretion measurement 365
The insulin secretions were preformed similar to previously described in our group 7, 9, 24 . 366 Fifty day 7 expanded islet clusters (cell number is comparable to 1/10 of primarily isolated 367 islets, 1,000~2,000 cells) or ten islets for each group were starved in 2.8 mM glucose 368 MKRBB buffer (5 mM KCl, 120 mM NaCl, 15 mM Hepes, 24 mM NaHCO 3 , 1 mM MgCl 2 , 2 369 mM CaCl 2 , pH=7.4) for 1 hour at 37℃, and then treated with 20 mM glucose and 100 nM 370 GLP1, whereas the control groups were treated with 2.8 mM glucose for 30 min. The 
Somatostatin measurement 376
The somatostatin secretions were preformed similar to previously described in our 377 group 7,9,24 . Fifty day 7 expanded islet clusters or ten primary islets for each group were 378 starved in 1 mM glucose MKRBB buffer for 1 hour at 37℃, then treated with 20 mM glucose 379 and 100 nM UCN3, whereas the control groups were treated with 1 mM glucose for 1 hour. 380
The supernatant fractions were collected for somatostatin measurement using the Phoenix 381 Pharmaceuticals ELISA kit (EK-060-03), as what indicated by the manufacturer's 382
instructions. 383
Glucagon measurement 385
The glucagon secretions were preformed similar to previously described in our group 7, 9, 24 . 386 Fifty day 7 expanded islet clusters or ten primary islets for each group were starved in 12 mM 387 glucose MKRBB buffer for 1 hour at 37℃, and then treated with 1 mM glucose and 25 mM 388 Arginine, whereas the control groups were treated with 5 mM Arginine for 1 hour. The 389 supernatant fractions were collected to measure the secreted glucagon. The glucagon levels 390
were measured with the Cloud-Clone Corp Mouse Glucagon (Cat. CEB266Mu), as what 391 indicated by the manufacturer's instructions. 392
393
Statistical analysis 394
All the qRT-PCR data were performed independently for at least three times. Statistical 395 analyses were performed using GraphPad Prism 7 software. Experimental data were 396 performed using unpaired two-tailed Student's t-test. Results are presented as mean ± SEM; P 397 < 0.05 was considered statistically significant. 
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After the islets were isolated from pregnant mice or wild-type rats, the islets were digested 596 into appropriate cell clusters by incubation with the dispase II. The digestion time were 597 optimized and the mechanical blow force was used for clusters generation. These clusters 598 were cultured 3D in PIEM to achieve the in vitro expansion of the islet cell clusters. 599
